Dr. Patnaik is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4383 Medical Dr
Fl 3
San Antonio, TX 78229Phone+1 210-593-2570Fax+1 210-615-1178- Is this information wrong?
Education & Training
- University of Toronto Faculty of MedicineClass of 1992
Certifications & Licensure
- TX State Medical License 2000 - 2025
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Top Doctors:SE Texas Castle Connolly, 2013
Clinical Trials
- A Phase I, Study to Evaluate the Safety and Tolerability of Intravenous EZN-2208 in Patients With Advanced Solid Tumors or Lymphoma (EZN-2208-02) Start of enrollment: 2007 May 01
- Evaluation of Safety, Tolerability, PK & PD of Intravenous VX15/2503 in Patients With Advanced Solid Tumors Start of enrollment: 2011 Jan 01
- A Dose Escalation Study of OMP-52M51 in Subjects With Solid Tumors Start of enrollment: 2013 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- A phase 1b open-label study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of py314 in combination with pembrolizumab in patients with ad...Kathryn E Beckermann, Amita Patnaik, Ira Winer, Winston Tan, Babar Bashir, Christos E Kyriakopoulos, Randy F Sweis, Marc Chamberlain, Brian I Rini> ;Investigational New Drugs. 2024 Apr 1
- A Relative Bioavailability, Bioequivalence, and Food Effect Study of Niraparib Tablets in Patients with Advanced Solid Tumors.Gerald Falchook, Amita Patnaik, Debra L Richardson, R Donald Harvey, Manish R Sharma, Navid Hafez, Erika Hamilton, Sarina A Piha-Paul, Minal Barve, Trisha Wise-Draper,...> ;Clinical Therapeutics. 2024 Feb 23
- First-in-human phase I dose escalation trial of the first-in-class tumor microenvironment modulator VT1021 in advanced solid tumors.Bullock, A., Watnick, R., Vincent, M., Chen, J., Wang, S., Pestana, H., Chao, J., Mahoney, J., Cieslewicz, M., Watnick, J., Mahalingam, D., Harb, W., Patnaik, A.> ;Communications Medicine. 2024 Jan 13
- Join now to see all
Press Mentions
- selfBACK App Developed by Norwegian University of Science Can Help Relieve Back PainAugust 3rd, 2021
- START Launches New Phase I Clinical Trial Program in UtahJune 8th, 2021
- Nektar Therapeutics Announces Its First Publication of Preclinical Data Highlighting Anti-Tumor Properties of IL-15 Agonist, NKTR-255, in the Journal for ImmunoTherapy of Cancer (JITC)May 18th, 2021
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
- Methodist HospitalSan Antonio, Texas
- Northeast Baptist HospitalSan Antonio, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: